Diabetic Retinopathy Independently Tied to Depression

This article originally appeared here.
Share this content:
Diabetic Retinopathy Independently Tied to Depression
Diabetic Retinopathy Independently Tied to Depression

THURSDAY, July 7, 2016 (HealthDay News) -- Severe nonproliferative diabetic retinopathy (NPDR) or PDR, but not diabetic macular edema (DME), is associated with depressive symptoms, according to a study published online July 7 in JAMA Ophthalmology.

Gwyneth Rees, Ph.D., from the University of Melbourne in Australia, and colleagues conducted a cross-sectional study in a tertiary eye hospital involving 519 patients with diabetes (median duration of diabetes, 13 years). They assessed how the severity of DR and DME correlated with symptoms of depression and anxiety.

In raw scores, 15.4 percent of patients screened positive for depressive symptoms and 22.7 percent screened positive for symptoms of anxiety. The researchers found that there was an independent correlation between severe NPDR/PDR and greater depressive symptoms after adjustment for sociodemographic factors and clinical characteristics, including visual acuity. Overall, 60.6 percent of the unique variance in depressive symptoms was due to a history of depression or anxiety, while severe NPDR or PDR accounted for 19.1 percent of the total explained variance of depressive symptoms. There was no correlation for DME with depressive symptoms. There was no correlation observed between DR and symptoms of anxiety.

"The severity of DR could be an indicator to prompt monitoring of depression in at-risk individuals with diabetes," the authors write. "Further work is required to replicate these findings and determine the clinical significance of the association."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »